GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
106 hedge funds and large institutions have $400M invested in GenMark Diagnostics, Inc in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 10 closing their positions.
13% more capital invested
Capital invested by funds: $355M → $400M (+$45.8M)
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
1% more funds holding
Funds holding: 105 → 106 (+1)
0% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.93M |
| 2 |
BlackRock
New York
|
+$1.84M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.4M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$1.12M |
| 5 |
D.E. Shaw & Co
New York
|
+$842K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$7.28M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$4.76M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.52M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.47M |
| 5 |
Morgan Stanley
New York
|
-$1.2M |
GNMK Hedge Fund Activity: Q3 2018 in Review
106 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2018, worth a combined $400M — up 13% from $355M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GNMK positions and 10 closed out — a net gain of 1 holder — while 34 added to existing stakes and 34 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $1.93M. The largest seller was Alyeska Investment Group, cutting an estimated $7.28M.
- 106 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2018, up from 105 in Q2 2018.
- Funds reported $400M of GenMark Diagnostics, Inc stock for Q3 2018, up 13% quarter-over-quarter.
- 11 funds opened new GenMark Diagnostics, Inc positions in Q3 2018 and 10 closed out, a net change of +1 holder.
- The largest GenMark Diagnostics, Inc buyer in Q3 2018 was Deutsche Bank, an estimated $1.93M added.
- The largest GenMark Diagnostics, Inc seller in Q3 2018 was Alyeska Investment Group, an estimated $7.28M sold.
Based on aggregated 13F filings for Q3 2018.